ISSN 2413-6166 (Online) · ISSN 1991-0290 (Print) · DOI prefix 10.17721/moca
УкрEn
Відкритий доступ · CC BY 4.0

Fluorimetric Derivatization-Based HPLC-FL Method for the Prototype Pharmacokinetic Analysis of Selexipag in Human Plasma

Burhan Ceylan, Meltem Çayci, Cem Önal, Armağan Önal
ÖnalII
† Harran University, Faculty of Pharmacy, Department of Pharmacognosy, Sanliurfa, Turkey;
‡ Harran University, Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Sanlıurfa, Turkey;
§ Istanbul Health and Technology University, Faculty of Pharmacy, Department of Analytical Chemistry, Istanbul, Turkey; II Istanbul University, Faculty of Pharmacy, Department of Analytical Chemistry, 34116 Beyazit-Istanbul, Turkey *e-mail: b.ceylan022@gmail.com

Анотація

A simple and cost-effective HPLC-FL method has been developed for measuring selexipag in human plasma, showcasing its suitability for pharmacokinetic research. Selexipag was precolumn derivatized with 7-chloro-4-nitrobenzofurazan (NBD-Cl) and the fluorescent derivative was separated on a C18 (150 mm × 4.6 mm × 2.6 μm) analytical column at 30 ºC using a mobile phase composed of acetonitrile – 0.1% o-phosphoric acid in water (70:30, v/v) by isocratic elution with flow rate of 1.0 mL min-1. The method was based on measuring the derivative using fluorescence detection (λex = 380 nm, λem = 420 nm). The retention time of selexipag is 6.40 ± 0.01 min. This currently developed method was validated according to EMA criteria by evaluating the specificity, linearity, precision, accuracy, and robustness. The method was determined to be linear in a concentration range of 0.01-20 ng mL-1 with a correlation coefficient of 0.9998. LOD and LOQ were found to be 0.003 and 0.01 ng mL-1, respectively. Intraday and interday RSD values were less than 1.75%. The plasma concentration-time profile and pharmacokinetic parameters such as AUC0–t, AUC0–∞, Cmax, tmax, t1/2, were calculated according to the assays. The presented method can be effectively used for bioequivalence and bioavailability investigations, as well as for routine analysis of the drug in plasma.

Ключові слова:selexipagHPLC-FLpre-column derivatizationpharmacokineticsNBD-Cl

Як цитувати

Burhan Ceylan, Meltem Çayci, Cem Önal, Armağan Önal. Fluorimetric Derivatization-Based HPLC-FL Method for the Prototype Pharmacokinetic Analysis of Selexipag in Human Plasma. Methods Objects Chem. Anal. 2025, 20(2), 117-122. https://doi.org/10.17721/moca.2025.117-122